Literature DB >> 7919576

Intravenous ciprofloxacin dosing in a morbidly obese patient.

J B Caldwell, A K Nilsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7919576     DOI： 10.1177/106002809402800622

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  6 in total

Review 1.  Effects of obesity on pharmacokinetics implications for drug therapy.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

Review 2.  Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.

Authors:  Teena Chopra; Jing J Zhao; George Alangaden; Michael H Wood; Keith S Kaye
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

Review 3.  Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.

Authors:  Claudia Langebrake; Friederike Bernhardt; Michael Baehr; Nicolaus Kröger; Axel R Zander
Journal:  Int J Clin Pharm       Date:  2011-09-29

Review 4.  Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.

Authors:  D T Bearden; K A Rodvold
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

Review 5.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 6.  Dosing of medications in morbidly obese patients in the intensive care unit setting.

Authors:  Brian L Erstad
Journal:  Intensive Care Med       Date:  2003-11-19       Impact factor: 17.440
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.